Search results
Mar 1, 2024 · Soliris (eculizumab) is indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis, the treatment of patients with atypical hemolytic uremic syndrome and the treatment of adult patients with generalized Myas.
SOLIRIS ® (eculizumab) is an FDA-approved prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive. It is not known if SOLIRIS is safe and effective in children with NMOSD. Learn About SOLIRIS.
SOLIRIS is the first and only FDA-approved drug for the treatment of NMOSD in adult patients who are anti-AQP4 antibody positive. The safety and efficacy of SOLIRIS were established in a phase 3, randomized, double-blind, placebo-controlled, multicenter, time-to-event trial in adults with anti-AQP4 antibody-positive NMOSD (PREVENT, N=143).
Apr 10, 2024 · Soliris (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells in people with a genetic condition that affects the natural defenses of red blood cells used to prevent the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinemia (PNH) and Atypical Hemolytic Uremic Syndrome...
SOLIRIS ® (eculizumab) is the first FDA-approved treatment for adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD). SOLIRIS may help treat your anti-AQP4 antibody-positive NMOSD, regardless of how many relapses you’ve had or when you were diagnosed.
SOLIRIS ® (eculizumab) is the first FDA-approved complement inhibitor indicated for the treatment of adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD). 1.
Jun 6, 2024 · Soliris (eculizumab) Contents. Generic. FAQ. Side effects. Dosage. Uses. Interactions. Cost and coupons. Similar drugs. Considerations. Precautions. Soliris is a brand-name injection that’s...
Eculizumab, sold under the brand name Soliris among others, is a recombinant humanized monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica.
Sep 29, 2023 · Soliris is a prescription medicine called a monoclonal antibody. Soliris is used to treat: patients-with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH). adults and children with a disease called atypical Hemolytic Uremic Syndrome (aHUS).
SOLIRIS is a prescription medicine used to treat: • people with paroxysmal nocturnal hemoglobinuria (PNH). . • people with atypical hemolytic uremic syndrome (aHUS). iga toxin E. coli related hemol. • adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody positive.
